Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
Plasmacytoid dendritic cells (pDCs) sense viral and microbial DNA through endosomal Toll-like receptors to produce type 1 interferons. pDCs do not normally respond to self-DNA, but this restriction seems to break down in human autoimmune disease by an as yet poorly understood mechanism. Here we identify the antimicrobial peptide LL37 (also known as CAMP) as the key factor that mediates pDC activation in psoriasis, a common autoimmune disease of the skin. LL37 converts inert self-DNA into a potent trigger of interferon production by binding the DNA to form aggregated and condensed structures that are delivered to and retained within early endocytic compartments in pDCs to trigger Toll-like receptor 9. Thus, our data uncover a fundamental role of an endogenous antimicrobial peptide in breaking innate tolerance to self-DNA and suggest that this pathway may drive autoimmunity in psoriasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the anti-microbial peptide LL37 has been shown to promote trafficking of aggregated DNA structures to the early endosome, promoting TLR9 activation and interferon production (Lande et al., 2007)”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Lande et al., 2007
In the citing paper
“Interestingly, suction blister wounds, where the blister roof is still intact, do not show substantial inflammation,9 whereas excisional wounds, ultraviolet (UV)-induced skin damage, superficial tape stripping or chemical skin irritants, and contact sensitizers cause inflammatory infiltrates,17,23–26”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [23]
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,245
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Self-citationEndogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
Pathogenesis and therapy of psoriasis
Lowes, M. A., Bowcock, A. M., & Krueger, J. G. (2007) · Nature · doi:10.1038/nature05663 · Cited by 1,778
Plasmacytoid dendritic cells in immunity
Colonna, M., Trinchieri, G., & Liu, Y.-J. (2004) · Nature Immunology · doi:10.1038/ni1141 · Cited by 1,678
Self-citation
Cited by
Items 901–1,000 of 1,000
Neutrophil as a multifunctional relay in immune system
Dolgushin, I. I., Анатольевна, М. Е., Savochkina, A. Y., & Kuznetsova, E. K. (2019) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-2019-1-9-38 · Cited by 44
Unbalanced Sphingolipid Metabolism and Its Implications for the Pathogenesis of Psoriasis
Bocheńska, K., & Gabig‐Cimińska, M. (2020) · Molecules · doi:10.3390/molecules25051130 · Cited by 36
“In normal conditions, pDCs, unlike myeloid dendritic cells (mDCs), are hardly found in the tissues other than lymphatics [91].”
BackgroundThe immunomodulatory effect of cathelicidin-B1 on chicken macrophages
Peng, L., Scheenstra, M. R., van Harten, R. M., Haagsman, H. P., & Veldhuizen, E. J. A. (2020) · Veterinary Research · doi:10.1186/s13567-020-00849-y · Cited by 33
Dondalska, A., Rönnberg, E., Ma, H., Pålsson, S. A., Magnúsdóttir, E. I., Gao, T., Adam, L., Lerner, E. A., Nilsson, G. P., Lagerström, M. C., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.559589 · Cited by 33
“For instance, the antimicrobial peptide LL-37, the only member of the human cathelicidin family, has been implicated in the pathogenesis of both atopic dermatitis (2) and psoriasis (3).”
BackgroundGoing, Toll-like receptors in skin inflammation and inflammatory diseases
Kumar, V. (2021) · EXCLI journal · doi:10.17179/excli2020-3114 · Cited by 53
“The pathogenic T cells in psoriasis comprise Th1, Th22, and Th17 cells, along with pathogenic pro-inflammatory cytokines IL-17, IL-22, IFN-γ, TNF-α, IL-12, IL-1, and IL-23 (Grän et al., 2020; Lowes et al., 2014).”
BackgroundInfluentialInnate barriers against skin infection and associated disorders
Gallo, R. L., & Nizet, V. (2008) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2008.04.009 · Cited by 33
“In psoriasis, it has been recently proposed that the presence of LL-37 augments type-1 interferon release from plasmacytoid dendritic cells [ 63 ].”
BackgroundAlarmin‐induced cell migration
Yang, D., Wei, F., Tewary, P., Howard, O. M. Z., & Oppenheim, J. J. (2013) · European Journal of Immunology · doi:10.1002/eji.201243138 · Cited by 36
Göblös, A., Danis, J., Vas, K., Bata‐Csörgõ, Z., Kemény, L. V., & Széll, M. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.03.009 · Cited by 32
“Cytosolic DNA is a potent inducer of the innate immune response and has been proposed to be involved in the pathogenesis of psoriasis (Dombrowski et al., 2011; Lande et al., 2007; Nestle et al., 2009 a).”
BackgroundPolymorphonuclear neutrophils and instability of the atherosclerotic plaque: a causative role?
Bona, R. D., Cardillo, M. T., Leo, M., Biasillo, G., Gustapane, M., Trotta, F., & Biasucci, L. M. (2013) · Inflammation Research · doi:10.1007/s00011-013-0617-0 · Cited by 35
Structural modification of DNA—a therapeutic option in SLE?
Frese, S., & Diamond, B. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.153 · Cited by 35
The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitis
Schreiber, A., & Kettritz, R. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1012525 · Cited by 33
García‐Quiroz, J., García-Becerra, R., Santos-Martínez, N., Avila, E., Larrea, F., & Díaz, L. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0298-4 · Cited by 33
“These effects are the result of tissue-specific signaling pathways triggered by CAMP in an intra- or extra-cellular manner [9] involving several growth factor receptors [10–12] and/or toll-like receptors [13].”
BackgroundKim, H. J., Roh, J. Y., & Jung, Y. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.03.1509 · Cited by 33
Tanaka, A., Ito, T., Kibata, K., Inagaki‐Katashiba, N., Amuro, H., Nishizawa, T., Son, Y., Ozaki, Y., & Nomura, S. (2019) · Lupus · doi:10.1177/0961203319862865 · Cited by 32
Purinergic Signaling and Inflammasome Activation in Psoriasis Pathogenesis
Ferrari, D., Casciano, F., Secchiero, P., & Reali, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179449 · Cited by 34
“P2X7 signaling in antigen-presenting DC has been shown to increase the expression of CD80 and CD86 and activate a cascade of proinflammatory events, including STAT1 phosphorylation and IFNγ production.”
BackgroundMylonas, A., Hawerkamp, H. C., Wang, Y., Chen, J., Messina, F., Demaria, O., Meller, S., Homey, B., Domizio, J. D., Mazzolai, L., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.151846 · Cited by 32
“It can, however, become a potent trigger of pDC activation in the presence of cathelicidin peptides (16).”
InfluentialSelf-citationThe LL-37 domain: A clue to cathelicidin immunomodulatory response?
Leite, M. L., Duque, H. M., Rodrigues, G. R., da Cunha, N. B., & Franco, O. L. (2023) · Peptides · doi:10.1016/j.peptides.2023.171011 · Cited by 33
Connections between antiviral defense and autoimmunity
Stetson, D. B. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.005 · Cited by 35
Miyamoto, R., Ito, T., Nomura, S., Amakawa, R., Amuro, H., Katashiba, Y., Ogata, M., Murakami, N., Shimamoto, K., Yamazaki, C., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3014 · Cited by 29
“(high-mobility group box 1 protein; HMGB1), which help to promote stabilization and delivery of immune complexes into early endosomes [9,41,42].”
Coch, C., Busch, N., Wimmenauer, V., Hartmann, E., Janke, M., Abdel-Mottaleb, M. M. A., Lamprecht, A., Ludwig, J., Barchet, W., Schlee, M., et al. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0509314 · Cited by 30
“It has been proposed that triggering of TLR9 by self-DNA bound to LL37 contributes to the pathogenesis of psoriasis [26].”
BackgroundZhu, Y. J., Zhou, Y. Q., Ma, X.-N., Duan, Z., Xu, H. H., Li, Y., Kong, Y., Yang, L., & Xin, X. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030283 · Cited by 32
Espinoza, L. (2011) · Drug Design Development and Therapy · doi:10.2147/dddt.s10494 · Cited by 29
“Plasmacytoid dendritic cells are activated through complexes of antimicrobial peptides LL-37 cathelicidin and DNA in a toll-like receptor9-dependent manner, which may explain how immunological tolerance is disrupted in patients with psoriasis.(14) More recently, increasing attention has been focused on keratinocytes,…”
Breakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic Cells
Liao, X., Reihl, A. M., & Luo, X. (2016) · Journal of Immunology Research · doi:10.1155/2016/6269157 · Cited by 31
“In addition, nucleic acid self-antigens and/or nucleic acid-containing ICs are another potential inducer of TLR7/9-dependent IFN 𝛼 production by pDC in lupus [128].”
Baumann, A., Kiener, M., Haigh, B., Perreten, V., & Summerfield, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00059 · Cited by 32
“In both human and porcine models, it was proposed that pDC play a pivotal role in sensing of nucleic acids complexed to cathelicidin followed by the release of large quantities type I IFNs (19, 31).”
BackgroundInfluentialCouderc, E., Morel, F., Levillain, P., Buffière-Morgado, A., Camus, M., Paquier, C., Bodet, C., Jégou, J., Pohin, M., Favot, L., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181486 · Cited by 31
Stein, T., Wollschlegel, A., Té, H., Weiss, J., Joshi, K., Kinzel, B., Billich, A., Guntermann, C., & Lehmann, J. (2018) · FEBS Journal · doi:10.1111/febs.14600 · Cited by 31
Granzyme A Stimulates pDCs to Promote Adaptive Immunity via Induction of Type I IFN
Shimizu, K., Yamasaki, S., Sakurai, M., Yumoto, N., Ikeda, M., Mishima-Tsumagari, C., Kukimoto‐Niino, M., Watanabe, T., Kawamura, M., Shirouzu, M., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01450 · Cited by 32
Kundu, B., Raychaudhuri, D., Mukherjee, A., Sinha, B. P., Sarkar, D., Bandopadhyay, P., Pal, S., Das, N., Dey, D., Ramarao, K., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00532 · Cited by 30
Xu, Y., Li, P., Li, K., Li, N., Liu, H., Zhang, X., Liu, W., & Liu, Y. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102890 · Cited by 32
Self-citationMiura, S., Garcet, S., Li, X., Cueto, I., Salud-Gnilo, C., Kunjravia, N., Yamamura, K., Gonzalez, J., Murai‐Yamamura, M., Rambhia, D., et al. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.10.017 · Cited by 33
Programmed death-ligand 1, 2 expressions are decreased in the psoriatic epidermis
Kim, J. H., Je, J. H., Kim, S. H., Shin, D., Kim, T., Kim, D. Y., Kim, S. M., & Lee, M. (2015) · Archives of Dermatological Research · doi:10.1007/s00403-015-1588-5 · Cited by 31
“It has been shown that LL-37 from keratinocytes binds to nucleic acids and enables them to activate plasmacytoid DCs (pDCs) and myeloid DCs through intracellular Toll-like receptors (TLRs) [11, 12, 17].”
BackgroundThe 2011 Nobel Prize in Physiology or Medicine
Volchenkov, R., Sprater, F., Vogelsang, P., & Appel, S. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02663.x · Cited by 29
Leprosy and the natural selection for psoriasis
Bassukas, I. D., Gaitanis, G., & Hundeiker, M. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.10.022 · Cited by 29
“The prevalence of psoriasis has been associated with gene polymorphisms that result in excessive activation of the processes of natural immunity [13–16].”
BackgroundInnate immune recognition of nucleic acids
Xiao, T. S. (2008) · Immunologic Research · doi:10.1007/s12026-008-8053-x · Cited by 34
“Future structural characterization of various ODNs in complex with TLR9 will reveal Immunol Res.”
BackgroundInfluentialBierkarre, H., Harder, J., Cuthbert, R., Emery, P., Leuschner, I., Mrowietz, U., Hedderich, J., McGonagle, D., & Gläser, R. (2015) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2015.1091497 · Cited by 30
“In this regard, these AMPs have been reported to enable plasmacytoid dendritic cells (pDCs) to recognize self-DNA released from damaged cells leading to the increased secretion of type I interferons (8, 36).”
BackgroundAmatngalim, G. D., Nijnik, A., Hiemstra, P. S., & Hancock, R. E. W. (2011) · Inflammation · doi:10.1007/s10753-010-9248-6 · Cited by 24
“These include chemokine induction [13, 16, 17], stimulation of mast cell antimicrobial and pro-inflammatory functions [18, 19], stimulation of dendritic cell activation in synergy with oligonucleotides [20, 21], modulation of neutrophil survival [22–24], and promotion of cytokine production in combination with IL-1β […”
BackgroundNETosis of psoriasis: a critical step in amplifying the inflammatory response
Zhang, J., Feng, Y., & Shi, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1374934 · Cited by 35
“This immune response involves the production of TNF-a and IL-6 (41, 73).”
BackgroundIs Psoriatic Arthritis a Result of Abnormalities in Acquired or Innate Immunity?
Lories, R. J. U., & de Vlam, K. (2012) · Current Rheumatology Reports · doi:10.1007/s11926-012-0257-3 · Cited by 30
“Natural barrier molecules of the skin with antibacterial properties such as LL-37, produced by keratinocytes, may play a pivotal role in the initiation of the inflammatory cascade by binding to nucleic acid fragments and activating skin plasmacytoid dendritic cells that trigger the production of type 1 interferons (IF…”
BackgroundImmunomodulatory approaches for prevention and treatment of infectious diseases
Nijnik, A. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.011 · Cited by 29
RIPK1 downregulation in keratinocyte enhances TRAIL signaling in psoriasis
Saito, N., Honma, M., Shibuya, T., Iinuma, S., Igawa, S., Kishibe, M., & Ishida‐Yamamoto, A. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.04.007 · Cited by 28
Niedźwiedzka‐Rystwej, P., Repka, W., Tokarz–Deptuła, B., & Deptuła, W. (2019) · Journal of Inflammation · doi:10.1186/s12950-019-0222-2 · Cited by 33
Cuevas, E. S., Ouaguia, L., Mouret, S., Charles, J., de Fraipont, F., Manches, O., Valladeau‐Guilemond, J., Bendriss‐Vermare, N., Chaperot, L., & Aspord, C. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1190 · Cited by 35
Domínguez-Díaz, C., Varela-Trinidad, G. U., Muñoz-Sánchez, G., Solórzano-Castanedo, K., Avila-Arrezola, K. E., Íñiguez-Gutiérrez, L., Delgado‐Rizo, V., & Fafutis‐Morris, M. (2021) · Cells · doi:10.3390/cells10061469 · Cited by 36
Anti-Carbamylated LL37 Antibodies Promote Pathogenic Bone Resorption in Rheumatoid Arthritis
O’Neil, L. J., Oliveira, C. B., Sandoval-Heglund, D., Barrera‐Vargas, A., Merayo‐Chalico, J., Aguirre-Aguilar, E., Kaplan, M. J., & Carmona‐Rivera, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.715997 · Cited by 28
Crosstalk between keratinocytes and immune cells in inflammatory skin diseases
Ni, X., & Lai, Y. (2021) · Exploration of Immunology · doi:10.37349/ei.2021.00028 · Cited by 32
“IL-1β and IL-23 drive human naive CD4+ T cells differentiation into Th17 cell [39], while IL-6, together with TGFβ, promotes murine naive CD4+ T cells development into Th17 cell [40], and then IL-23 activates Th17 cells to produce IL-17A, IL-17F, IL-22 and other cytokines [17, 18, 41-43].”
Modulation of plasmacytoid dendritic cells response in inflammation and autoimmunity
Kioon, M. D. A., Laurent, P., Chaudhary, V., Du, Y., Crow, M. K., & Barrat, F. J. (2024) · Immunological Reviews · doi:10.1111/imr.13331 · Cited by 32
Benítez‐Ribas, D., Tacken, P. J., Punt, C. J. A., de Vries, I. J. M., & Figdor, C. G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5219 · Cited by 28
“Chloroquine prevents endosomal maturation primarily through inhibition of vesicular acidification (21) (22).”
BackgroundExpression of antimicrobial peptides and proteins in etanercept-treated psoriasis patients
Gambichler, T., Kobus, S., Kobus, A., Tigges, C., Scola, N., Altmeyer, P. J., Kreuter, A., Bechara, F. G., & Skrygan, M. (2011) · Regulatory Peptides · doi:10.1016/j.regpep.2011.02.001 · Cited by 28
Rigid Interferon-α Subtype Responses of Human Plasmacytoid Dendritic Cells
Szubin, R., Chang, W. L. W., Greasby, T. A., Beckett, L. A., & Baumgarth, N. (2008) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0037 · Cited by 30
“…A-class and C-class CpG’s in their ability to induce different levels of IFN-α responses by pDC are well appreciated and the mechanisms are thought to involve the kinetics of endosomal degradation of various TLR9 agonists (Rothenfusser and others 2002; Honda and others 2005; Lande and others 2007).”
InfluentialKim, S., Hur, M. S., Choi, B. G., Kim, M., Lee, Y. W., Choe, Y., & Ahn, K. J. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12888 · Cited by 30
“In psoriasis self-nucleic acid gain access to intracellular TLR 7 and 9 when complexed with endogenous LL-37 to trigger high levels of type I interferons in plasmacytoid dendritic cell [10,11].”
Paz, S., Hsiao, J., Cauntay, P., Soriano, A., Bai, L., Machemer, T., Xiao, X., Guo, S., Hung, G., Younis, H. S., et al. (2017) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0668 · Cited by 28
“The localization of TLR9 to the endosomal compartment allows efficient detection of IONIS Pharmaceuticals, Carlsbad, California. foreign material, while preventing unwanted detection of self-DNA [18,19].”
Kao, C. C., Lin, X., Yi, G., Zhang, Y., Rowe‐Magnus, D. A., & Bush, K. (2016) · mBio · doi:10.1128/mbio.01418-16 · Cited by 27
Hoffmann, J. H. O., Schaekel, K., Hartl, D., Enk, A., & Hadaschik, E. N. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15839 · Cited by 32
Brown, F. F., Campbell, J. P., Wadley, A. J., Fisher, J. P., Aldred, S., & Turner, J. E. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.05.012 · Cited by 29
The role of extracellular DNA (exDNA) in cellular processes
Fernández-Domínguez, I. J., Manzo-Merino, J., Taja‐Chayeb, L., Dueñas‐González, A., Pérez‐Cárdenas, E., & Trejo‐Becerril, C. (2021) · Cancer Biology & Therapy · doi:10.1080/15384047.2021.1890319 · Cited by 29
“exDNA bound to different molecules forms stable structures, which ensure recognition and interaction with various receptors like TLR-9.(79,89) Recently, it has been pointed out that exDNA can bind to”
BackgroundPathogenesis-oriented therapy of psoriasis using biologics
Boehncke, W., & Brembilla, N. C. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2100219 · Cited by 32
“defined cascade starting with keratinocyte damage results in release of self-nucleic acids, which are subsequently complexed to antimicrobial peptides, and sensed by plasmacytoid dendritic cells (pDCs) [5].”
BackgroundMulti-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis
Rusiñol, L., & Puig, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021042 · Cited by 32
“LL37 interacts and forms complexes with self-DNA or -RNA that will trigger the innate immune system via Toll-like receptors (TLR) [31,32].”
BackgroundHeier, I., Søyland, E., Krogstad, A., Rodríguez‐Gallego, C., Nenseter, M. S., & Jahnsen, F. L. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10430.x · Cited by 31
Takenaka, N., Edamatsu, H., 昇, 鈴., Saito, H., Inoue, Y., Oka, M., Hu, L., & Kataoka, T. (2010) · European Journal of Immunology · doi:10.1002/eji.201040675 · Cited by 29
Hamilos, G., Samonis, G., & Kontoyiannis, D. P. (2012) · International Journal of Microbiology · doi:10.1155/2012/583792 · Cited by 28
“Finally, in humans, evolutionarily conserved antimicrobial peptides exert important immunomodulatory properties besides their direct effector function, by acting on various chemokine and signaling receptors [65, 66].”
BackgroundWang, F., Qiao, L., Lv, X., Trivett, A. L., Yang, R., Oppenheim, J. J., Yang, D., & Zhang, N. (2016) · Cytokine · doi:10.1016/j.cyto.2016.03.015 · Cited by 28
“Several alarmins have been shown to promote pDC activation and IFN production, including LL-37, the only cathelicidin in humans [46,47], human β defensin 2 & 3 [48], and HMGB1 [49].”
BackgroundAdase, C. A., Borkowski, A. W., Zhang, L., Williams, M. R., Sato, E., Sanford, J. A., & Gallo, R. L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.725317 · Cited by 28
“Typically 500 –1000 ng of total RNA was reverse transcribed using an iScript cDNA synthesis kit (BioRad). mRNA transcript levels were evaluated by TaqMan Gene Expression Assays using 6-carboxyfluorescein-labeled predeveloped probes (Thermo Fisher).”
BackgroundInfluentialSaas, P., Varin, A., Perruche, S., & Ceroi, A. (2017) · F1000Research · doi:10.12688/f1000research.11332.2 · Cited by 29
Liu, C., Chu, X., Sun, P., Feng, X., Huang, W., Liu, H., & Ma, Y. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1420446 · Cited by 27
DNA‐Based Biomaterials for Immunoengineering
Maeda, M., Kojima, T., Song, Y., & Takayama, S. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201801243 · Cited by 27
The contribution of IL-17 to the development of autoimmunity in psoriasis
Furue, M., & Kadono, T. (2019) · Innate Immunity · doi:10.1177/1753425919852156 · Cited by 27
“LL-37 is an anti-microbial peptide of human cathelicidin that is produced when keratinocytes are injured by a broad range of bacteria.70 The released LL-37 binds to the infiltrated neutrophils.70 Neutrophils are a rich source of extracellular DNA due to their neutrophil extracellular traps.71 Upon stimulation with com…”
BackgroundThe path ahead for understanding Toll-like receptor-driven systemic autoimmunity
Hamerman, J. A., & Barton, G. M. (2024) · Current Opinion in Immunology · doi:10.1016/j.coi.2024.102482 · Cited by 31
The Regulation of Immune Responses by DC Derived Type I IFN
Ng, D., & Gommerman, J. L. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00094 · Cited by 33
“…cytokine in numerous immune settings such as autoimmune diseases like psoriasis and systemic lupus erythematosus (Nestle et al., 2005; Lande et al., 2007; Elkon and Stone, 2011), allograft rejection in transplantation (Tovey et al., 1996), and immunity against tumors (Diamond et al.,…”
BackgroundSakabe, J., Umayahara, T., Hiroike, M., Shimauchi, T., Ito, T., & TOKURA, Y. (2014) · Acta Dermato Venereologica · doi:10.2340/00015555-1775 · Cited by 30
An update on pathogenesis of systemic lupus erythematosus.
Ahmadpoor, P., Dalili, N., & Rostami, M. (2014) · Iranian Journal of Kidney Diseases · Cited by 37
Autoimmune, rheumatic, chronic inflammatory diseases: Neutrophil extracellular traps on parade
Podolska, M. J., Mahajan, A., Knopf, J., Hahn, J., Boeltz, S., Munoz, L. E., Bilyy, R. O., & i, M. H. (2018) · Autoimmunity · doi:10.1080/08916934.2018.1519804 · Cited by 29
“These pro-inflammatory cytokines foster the onset and clinical manifestations of psoriasis [80,81].”
BackgroundInterleukin-26 activates macrophages and facilitates killing of Mycobacterium tuberculosis
Hawerkamp, H. C., van Geelen, L., Korte, J., Domizio, J. D., Swidergall, M., Momin, A. A., Guzmán‐Vega, F. J., Arold, S. T., Ernst, J. F., Gilliet, M. F., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-73989-y · Cited by 31
Self-citationParticipation of interferons in psoriatic inflammation
Gu, H., Zhang, Y., Zeng, W., & Xia, Y. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.12.002 · Cited by 30
Małachowa, N., Kobayashi, S. D., Quinn, M. T., & DeLeo, F. R. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00259 · Cited by 33
“Indeed, NET-associated molecules have been shown to elicit inflammatory responses mediated by toll-like receptors (TLRs), which may, in turn, impact autoimmunity (88).”
BackgroundChakraborty, S., Chatterjee, R., & Chakravortty, D. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.05.002 · Cited by 30
“It is easy to imagine that such a nanostructure would lead to interdigitation of the DNA with a clustered, closely packed array of TLR9, leading to a ‘clustering’ of the immune ligands (Fig.”
BackgroundHoll, E. K., Shumansky, K. L., Pitoc, G. A., Ramsburg, E. A., & Sullenger, B. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069413 · Cited by 30
“Endosomal TLRs 3, 7 and 9 can be activated by endogenous nucleic acid ligands released from dead or dying cells [10,33,34].”
BackgroundPlasmacytoid Dendritic Cells Infiltrate the Skin in Positive Tuberculin Skin Test Indurations
Bond, E., Liang, F., Sandgren, K. J., Smed‐Sörensen, A., Bergman, P., Brighenti, S., Adams, W. C. T., Betemariam, S. A., Rangaka, M. X., Lange, C. G., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.246 · Cited by 26
“LL37-DNA stimulated pDC can regulate mDC and T cell function In line with earlier reports (Ganguly et al., 2009; Lande et al., 2007), we found that IFNα secretion by pDC exposed to complexes of LL37 and human DNA was enhanced compared to the low levels found in response to either LL37 or DNA alone…”
BackgroundResultInfluentialImmunological intervention in human diseases
Ueno, H., Hawrylowicz, C. M., & Banchereau, J. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-59 · Cited by 26
Murakami, Y., Fukui, R., Motoi, Y., Shibata, T., Saitoh, S.-I., Sato, R., & Miyake, K. (2017) · Scientific Reports · doi:10.1038/srep44042 · Cited by 27
The Role and Potential Application of Antimicrobial Peptides in Autoimmune Diseases
Zhang, C., & Yang, M. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00859 · Cited by 28
“These complexes can translocate into pDCs to activate IFN-α production in a TLR9-dependent manner (25), which promotes the progression of psoriasis.”
BackgroundCathelicidin Modulates Vascular Smooth Muscle Cell Phenotypic Switching through ROS/IL-6 Pathway
Dong, X., Wu, D., Zhang, Y., Jia, L., Pan, X., Sun, J., & Pan, L.-L. (2020) · Antioxidants · doi:10.3390/antiox9060491 · Cited by 25
naRNA-LL37 composite DAMPs define sterile NETs as self-propagating drivers of inflammation
Bork, F., Greve, C. L., Youn, C., Chen, S., Leal, V. N. C., Wang, Y., Fischer, B., Nasri, M., Focken, J., Scheurer, J., et al. (2024) · EMBO Reports · doi:10.1038/s44319-024-00150-5 · Cited by 36
“In addition, earlier work described a role for DNA-and RNA-LL37 complexes in the activation of plasmacytoid dendritic cells (Ganguly et al, 2009; Lande et al, 2007).”
Self-citationCleavage of Toll-Like Receptor 9 Ectodomain Is Required for In Vivo Responses to Single Strand DNA
Fukui, R., Yamamoto, C., Matsumoto, F., Onji, M., Shibata, T., Murakami, Y., Kanno, A., Hayashi, T., Tanimura, N., Yoshida, N., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01491 · Cited by 27
Gunter, N. V., Yap, B. J. M., Chua, C. L. L., & Yap, W. H. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00395 · Cited by 28
Badal, D., Dayal, D., Singh, G., & Sachdeva, N. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-65851-y · Cited by 29
Antigen-Presenting Cells in Psoriasis
Antal, D., Alimohammadi, S., Bai, P., Szöllősi, A. G., & Szántó, M. (2022) · Life · doi:10.3390/life12020234 · Cited by 31
“Certain triggering factors, such as epidermal injury may promote keratinocytes to excessively produce AMPs that have the ability to form complex with otherwise inert self-DNA and thereby act as strong inducers of pDC activation and secretion of IFNα in psoriatic skin [38].”
BackgroundRana, K., Pani, T., Jha, S. K., Mehta, D., Yadav, P., Jain, D., Pradhan, M. K., Mishra, S., Kar, R., Betsy Reshma, G., et al. (2022) · Nanoscale · doi:10.1039/d1nr06001e · Cited by 26
Perić, M., Koglin, S., Dombrowski, Y., Groß, K., Bradac, E., Ruzicka, T., & Schauber, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.08.010 · Cited by 25
Wu, P., Yu, Y., McGhee, C. E., Tan, L. H., & Lu, Y. (2014) · Advanced Materials · doi:10.1002/adma.201304891 · Cited by 25
Lupus eritematoso túmido, una entidad en proceso de definición
Rodríguez-Caruncho, C., & Bielsa, I. (2011) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2011.04.005 · Cited by 28
The NET , the trap and the pathogen: neutrophil extracellular traps in cutaneous immunity
Stephan, A., & Fabri, M. (2015) · Experimental Dermatology · doi:10.1111/exd.12599 · Cited by 28
Sweeney, C. M., Russell, S. E., Malara, A., Kelly, G., Hughes, R., Tobin, A., Adamzik, K., Walsh, P. T., & Kirby, B. (2015) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2015.12.011 · Cited by 25
Shockwaves prevent from heart failure after acute myocardial ischaemia via RNA /protein complexes
Gollmann‐Tepeköylü, C., Primeßnig, U., Pölzl, L., Graber, M., Lobenwein, D., Nägele, F., Kirchmair, E., Pechriggl, E. J., Grimm, M. F., & Holfeld, J. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13021 · Cited by 25
“Thereby, the cationic antimicrobial peptide LL37 has been described to be released upon mechanical stress, to form complexes with ribonucleic acids, to pass the cellular membrane and to subsequently activate intracellular TLRs [15].”
BackgroundTocilizumab reverses cerebral vasculopathy in a patient with homozygous SAMHD1 mutation
Henrickson, M., & Wang, H. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3600-2 · Cited by 26
Moura, A. K. A., Guedes, F., Machado, M. C. R., & Sotto, M. N. (2018) · Archives of Dermatological Research · doi:10.1007/s00403-018-1806-z · Cited by 25
“We may suggest that this cell population, as proposed in psoriasis pathogenesis [22, 30], may be triggered by LL37, which is known to be over expressed in skin samples of rosacea [43].”
BackgroundAlbanesi, C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-7020-6896-6.00064-8 · Cited by 26
Henriquez, J. E., Crawford, R. B., & Kaminski, N. E. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.02.013 · Cited by 25
“For example, systemic lupus erythematosus (SLE) develops as host cells die and pDC respond to host genomic material (Lande et al., 2007; Crispín et al., 2010).”
Medicinal signaling cells: A potential antimicrobial drug store
Khatibi, S. M. H., Kheyrolahzadeh, K., Barzegari, A., Saadat, Y. R., & Vahed, S. Z. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29728 · Cited by 27
“Moreover, it presents angiogenic, antiapoptotic and wound‐healing effects (Lande et al., 2007).”
BackgroundMeisch, J. P., Vogel, R. M., Schlatzer, D., Li, X., Chance, M. R., & Levine, A. D. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0612300 · Cited by 25
“For instance, the cathelicidin LL-37 binds and carries cytosolic bacterial DNA, resulting in the activation of TLR-9 and subsequently, DCs; acts as a chemoattractant; and in the presence of other inflammatory cytokines, enhances select cytokine secretion from PBMCs [5, 6].”
BackgroundSawai, C. M., Serpas, L., Neto, A. G., Jang, G., Rashidfarrokhi, A., Kolbeck, R., Sanjuan, M. A., Reizis, B., & Sisirak, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02475 · Cited by 20
Metadata
- Authors
- Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., Zal, T., Mellman, I., Schröder, J.-M., Liu, Y.-J., & Gilliet, M.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Genentech (US)
- Heinrich Heine University Düsseldorf (DE)
- King's College London (GB)
- Christian-Albrechts-Universität zu Kiel (DE)
- Corresponding author
- Gilliet, Michel
- ORCID
- Venue
- Nature
- Published
- 2007-09-16
- Volume
- 449
- Issue
- 7162
- Pages
- 564-569
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2084951281
- Cited by
- 1,910
- References
- 43
- Citations by year
- 2026: 54 · 2025: 61 · 2024: 87 · 2023: 81 · 2022: 94 · 2021: 93 · 2020: 89 · 2019: 97 · 2018: 92 · 2017: 118 · 2016: 105 · 2015: 81 · 2014: 113 · 2013: 120 · 2012: 181
- FWCI
- 38.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI074809)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- plasmacytoid dendritic cells, LL-37, antimicrobial peptides, self-DNA, TLR9, type I interferon, psoriasis, autoimmunity, innate immune tolerance, vaccine adjuvants, skin inflammation
- MeSH terms
- Autoantigens, Autoimmune Diseases, Dendritic Cells, DNA, Endocytosis, Humans, Psoriasis, Endosomes, Autoimmunity, Antimicrobial Cationic Peptides, Toll-Like Receptor 9, Cathelicidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.